Key result
Acute myocardial infarction patients have markedly higher NTproBNP and cTnI levels than angina patients.
Why the study?
Early and accurate detection of acute myocardial infarction is an important unmet clinical requirement.
Do levels of NTproBNP, cTnI, and fasting lipid profile differ between patients with acute myocardial infarction and angina?
Cross-Sectional (n=150)
No
Do levels of NTproBNP, cTnI, and fasting lipid profile differ between patients with acute myocardial infarction and angina?
p-value: p=<0.01
Elevated levels of NTproBNP, cTnI, and atherogenic lipid profiles are significantly associated with acute myocardial infarction compared to angina in patients presenting with acute chest pain.
May aid differentiation of AMI from angina in acute chest pain; leaves open prospective validation of diagnostic thresholds.
Background: Early and accurate detection of acute myocardial infarction (AMI) is an important unmet clinical requirement. The present study sought to evaluate the levels of N-terminal pro-brain natriuretic peptide (NTproBNP), cardiac troponin I (cTnI), fasting lipid profile, random blood sugar, and serum creatinine in AMI patients compared to angina patients. Methods: In a single-center, hospital-based, cross-sectional, observational, prospective study conducted at Gandhi Medical College, Secunderabad, from October-2018 to September-2019. A total of 150 patients aged above 40 years with acute chest pain (within 2-6 hours) and who were clinically susceptive of AMI and angina were investigated. The patients were divided into group I (50 AMI patients) and group II (100 angina patients). Levels of all biochemical parameters of blood were assessed. The statistical analyses were performed using the SPSS statistical software, version 15. A student t-test was used to compare the continuous variables between the two groups. Results: Out of 150 patients, higher male prevalence was found in both the groups (60% and 63%, respectively). Group I had higher levels of NTproBNP (2909±273pg/ml vs. 110±20.74pg/ml, P<0.01), cTnI (2.06±1.3ng/ml vs. 0.006±0.002ng/ml, P<0.01), and fasting lipid profile (total cholesterol:216±41.2mg/dl vs.201±32.5mg/dl, P<0.05, triglycerides:217.7±63.6 mg/dl vs. 175.3±48.8 mg/dl, P<0.01, low-density lipoprotein:141.7mg/dl±41.5 vs. 127.1±30.24 mg/dl, P<0.05, very low-density lipoprotein:43.4±12.8mg/dl vs. 35.1±9.8mg/dl, P<0.01) than group II, except low levels of high-density lipoprotein (31.2±3.83mg/dl vs. 38.9±4.32 mg/dl, P<0.01). Conclusion: Assessment of NTproBNP, cTnI, and fasting lipid profile may aid in the early diagnosis of AMI and its management.
No takes yet. Share an insight, caveat, or question.
Karpay et al. (2022) conducted a cross-sectional in Acute myocardial infarction and angina (n=150). Acute myocardial infarction vs. Angina was evaluated on Levels of NTproBNP (p=<0.01). Acute myocardial infarction patients had significantly higher levels of NTproBNP (2909 vs 110 pg/ml, P<0.01) and cTnI (2.06 vs 0.006 ng/ml, P<0.01) than angina patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: